N-DOSE AD: A Dose Optimization Trial of Nicotinamide Riboside in Alzheimer's Disease

Conditions:   Alzheimer Disease;   Dementia Interventions:   Other: Placebo;   Dietary Supplement: Nicotinamide Riboside supplementation 1000mg daily in total;   Dietary Supplement: Nicotinamide Riboside dose escalation (up to 3000 mg daily in total) Sponsors:   Haukeland University Hospital;   Haraldsplass Deaconess Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials